
Devyser Diagnostics AB: insider trades · Finland · FIN-FSA
FI:devyser-diagnostics-ab-158200SE0016588867FIFI·FIN-FSAMcap 1.5Bn€Healthcare
Discover the full directors' dealings record of Devyser Diagnostics AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Devyser Diagnostics AB has recorded 5 public disclosures. Market capitalisation: €1.5bn. The latest transaction was filed on 20 March 2026 — Purchase. Among the most active insiders: Mia Arnhult. All data is openly available.
Financial data
FY ended December 2025 · cache
Analyst consensus
3 analysts141.55 €Target 152.94 €(+70%)165.81 €
Income statement
Revenue250.5 M€
Gross profit201.9 M€81% margin
Net income−8.4 M€5.8% margin
Valuation
PER (trailing)100.1x
PER (forward)28.5x
P/Book4.2x
Beta0.82
Balance sheet & cash
Market cap1.51 Bn€
Total debt51.9 M€
Free Cash Flow−62.0 M€
Debt / Equity14%
Profitability & ownership
ROE4.4%
ROA4.7%
% insiders30.0%
% institutions47.7%
Last declaration on 20 March 2026